Karen Marder

发表

ROBUST MIXED EFFECTS MODEL FOR CLUSTERED FAILURE TIME DATA: APPLICATION TO HUNTINGTON'S DISEASE EVENT MEASURES.

Yuanjia Wang, Tanya P Garcia, Yanyuan Ma, 2017, The annals of applied statistics.

Frequency and profile of mild cognitive impairment in Parkinson's disease: A multicentre meta-analysis of neuropsychological data

Roger A. Barker, Thomas Foltynie, Karen Marder, 2009 .

Time‐varying proportional odds model for mega‐analysis of clustered event times

Tanya P Garcia, Karen Marder, Yuanjia Wang, 2019, Biostatistics.

Interater reliability and factor structure of the Unified Parkinson's Disease rating Scale motor examination.

Yaakov Stern, Marcus Richards, Lucien J. Cote, 1992 .

Assessing dependence, a unique feature of functional decline in Alzheimer's disease.

Yaakov Stern, Marcus Richards, Frederick W. Bylsma, 1992 .

A reliable standardized technique for dating the onset of Alzheimer's disease.

Yaakov Stern, Marcus Richards, Frederick W. Bylsma, 1992 .

Subtle neuropsychological changes in HIV+ gay men.

Yaakov Stern, Marcus Richards, Karen Marder, 1990 .

Comparison of medical conditions and neurological examination in early Alzheimer's disease and normal elderly.

Marcus Richards, Ginette Lafleche, Karen Marder, 1992 .

Cognitive function in normal individuals with subtle extrapyramidal signs resembles that of patients with Parkinson's disease.

Yaakov Stern, Marcus Richards, Lucien J. Cote, 1992 .

Time-varying Hazards Model for Incorporating Irregularly Measured, High-Dimensional Biomarkers.

Yuanjia Wang, Donglin Zeng, Karen Marder, 2020, Statistica Sinica.

Targeted Local Support Vector Machine for Age-Dependent Classification

Donglin Zeng, Karen Marder, Yuanjia Wang, 2014, Journal of the American Statistical Association.

Psychopathological Features in Alzheimer's Disease: Course and Relationship with Cognitive Status

Yaakov Stern, Karen Marder, Jason Brandt, 2003, Journal of the American Geriatrics Society.

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

Yaakov Stern, Karen Marder, Howard Andrews, 1996, The Lancet.

Familial aggregation of early‐ and late‐onset Parkinson's disease

Karen Marder, Stanley Fahn, Howard Andrews, 2003, Annals of neurology.

Tracking motor impairments in the progression of Huntington's disease

Jane S. Paulsen, Karen Marder, Ying Zhang, 2014, Movement disorders : official journal of the Movement Disorder Society.

Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease.

Yanyuan Ma, Karen Marder, Tianle Chen, 2012, Journal of probability and statistics.

Diagnosing Parkinson's disease using videotaped neurological examinations: Validity and factors that contribute to incorrect diagnoses

Karen Marder, Stanley Fahn, Elan D Louis, 2002, Movement disorders : official journal of the Movement Disorder Society.

The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics

Yaakov Stern, Karen Marder, Lin Feng, 1998 .

A 10‐item smell identification scale related to risk for Alzheimer's disease

Yaakov Stern, Karen Marder, K. Marder, 2005, Annals of neurology.

HIV-associated cognitive impairment before and after the advent of combination therapy

Yaakov Stern, Karen Marder, Giovanni Schifitto, 2011, Journal of NeuroVirology.

Combined effect of age and severity on the risk of dementia in Parkinson's disease

Yaakov Stern, Karen Marder, Elan D Louis, 2002, Annals of neurology.

Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2

Eden R Martin, Karen Marder, Tatiana Foroud, 2012, Annals of neurology.

Energy balance in early-stage Huntington disease.

Karen Marder, Carol N Boozer, K. Marder, 2005, The American journal of clinical nutrition.

Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

Christine Klein, Karen Marder, Luis Carrillo-Reid, 2012, Science Translational Medicine.

Seizures in Alzheimer disease: who, when, and how common?

Hyunmi Choi, Yaakov Stern, Karen Marder, 2009, Archives of neurology.

Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation

Nir Giladi, Karen Marder, Anat Mirelman, 2013, Movement disorders : official journal of the Movement Disorder Society.

A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci

Jennifer Mulle, Nir Giladi, Karen Marder, 2012, PLoS genetics.

Attitudes and Practices Among Internists Concerning Genetic Testing

Karen Marder, Paul S. Appelbaum, Meredith Stark, 2013, Journal of Genetic Counseling.

A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia

Linda Chang, Karen Marder, Giovanni Schifitto, 2005, Journal of magnetic resonance imaging : JMRI.

Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Karen Marder, Norman Arnheim, Ira Shoulson, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Dementia in Parkinson's disease

Yaakov Stern, Karen Marder, Richard Mayeux, 1994, Neurology.

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease

Karen Marder, K. Marder, 2007, Current neurology and neuroscience reports.

An observational study of cognitive impairment in amyotrophic lateral sclerosis.

Yaakov Stern, Karen Marder, Hiroshi Mitsumoto, 2006, Archives of neurology.

The Clinical Dementia Rating scale

Yaakov Stern, Karen Marder, George Dooneief, 1996, Neurology.

Picking away at frontotemporal dementia.

Karen Marder, Douglas Galasko, K. Marder, 2002, Neurology.

Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population

Karen Marder, Stanley Fahn, Andrew Browne, 2011, BMC Medical Genetics.

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives

Yaakov Stern, Karen Marder, Richard Mayeux, 1993, Annals of neurology.

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Norbert Schuff, Arthur W. Toga, John Seibyl, 2018, Annals of clinical and translational neurology.

Incidence and Predictors of Seizures in Patients with Alzheimer's Disease

Yaakov Stern, Karen Marder, Marilyn Albert, 2006, Epilepsia.

Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method.

Karen Marder, Stanley Fahn, Daniel Rabinowitz, 2008, Archives of neurology.

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset

Samuel Frank, Karen Marder, Christopher A. Ross, 2012, Human Genetics.

Nonparametric estimation of age-at-onset distributions from censored kin-cohort data

Karen Marder, Daniel Rabinowitz, Yuanjia Wang, 2007 .

The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease

Yaakov Stern, Karen Marder, Jason Brandt, 1997, Annals of neurology.

1.003 FACILITATING CLINICAL RESEARCH: THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS (NINDS) AND STROKE PARKINSON'S DISEASE COMMON DATA ELEMENTS PROJECT

Anthony E. Lang, Karen Marder, Daniel Weintraub, 2012 .

Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study

Karen Marder, Steven Shea, Richard Mayeux, 1996, Annals of neurology.